SCHEMBL20525844

SCHEMBL20525844

COc1ccc2c(Oc3ncc(NC(=O)CC(=O)Nc4cccc(C(F)(F)F)c4)cc3Cl)ccnc2c1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.49
HTT P42858 2/20 0.49
LMNA P02545 2/20 0.49
MAPT P10636 4/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 1/20 0.47
HSP90AA1 P07900 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
BRAF P15056 5/20 0.46
ALDH1A1 P00352 1/20 0.46
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46
KDR P35968 6/20 0.45
NPC1 O15118 1/20 0.43
MAPK14 Q16539 3/20 0.43
TNNI3K Q59H18 3/20 0.43
EGFR P00533 1/20 0.43
FGFR4 P22455 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20525758 0.91 HTT (0.49) SMN1; SMN2HTTLMNAMAPTMEN1
SCHEMBL20525766 0.89 ALDH1A1 (0.49) SMN1; SMN2MEN1KMT2ABRAFALDH1A1
SCHEMBL20525750 0.89 KDR (0.47) LMNAMAPTMEN1KMT2AKDR
SCHEMBL20525528 0.88 AXL (0.46) SMN1; SMN2MEN1KMT2AKDM4ENPSR1
SCHEMBL29693652 0.86 KDR (0.59) BRAFKDRMAPK14TNNI3KEGFR
SCHEMBL378510 0.86 KDR (0.59) BRAFKDRMAPK14TNNI3KEGFR
SCHEMBL20525674 0.86 AXL (0.53) SMN1; SMN2MAPTKMT2AL3MBTL1KDR
SCHEMBL20525771 0.82 KDR (0.53) NPSR1ALDH1A1KDR
SCHEMBL20525555 0.79 AXL (0.52) KMT2AKDREGFR
SCHEMBL20525705 0.79 AXL (0.45) SMN1; SMN2KMT2AALDH1A1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2101759-B1 METHODS OF USING MEK INHIBITORS EXELIXIS INC (US) 2018-10-10 EP claimed